4.65 DESTINY BREAST 04 - A complex trial to deconstruct

Plenary Session - A podcast by Vinay Prasad, MD MPH

Categories:

Science & Medicine

My take on the standing ovation for DESTINY Breast 04 Traztuzumab Deruxtecan vs. Investigator choice after endocrine therapy and 1 or 2 chemotherapies for HER2 low